ClinicalTrials.gg
Status unknownNCT02876133Updated Sep 26, 2018

Narrow Band Imaging Versus White Light for Colonoscopy Serrate Lesions Detection

An interventional study of narrow band imaging withdrawal and white light withdrawal in Colon Cancer and Colon Sessile Serrated Adenoma/Polyp, sponsored by Hospital Beatriz Ângelo. Status unknown at 3 sites in Portugal. Open to participants aged 40 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-09-26.

Sponsored by Hospital Beatriz Ângelo · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Sep 2018), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
987
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Colonic Neoplasms with a site in Portugal — 2 open to participants now, 3 under way, 2 of them phase 3. Colonic Neoplasms · Portugal.

Planned enrollment
5th of 12
987 · median 874
Started
2016
the only one that year
No phase
4 of 18
1 open now
Registered
10th of 18
by date
Lead sponsor
1 of 18
Hospital Beatriz Ângelo

Among the 18 studies in Colonic Neoplasms with a site in Portugal, this one is the 5th largest by planned enrollment of the 12 interventional ones that give a count, is the only one that started in 2016, is one of 4 with no phase, and was the 10th registered.

Colonic Neoplasms

2,457 studies on the registry are indexed under Colonic Neoplasms; 456 are open to participants now.

Browse Colonic Neoplasms studies →

Open to participants now

2 of the 18 studies in Colonic Neoplasms with a site in Portugal are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →

Who these studies take

Of the 326 Colonic Neoplasms studies recruiting now, 202 (62%) set no upper age limit and 72 (22%) stop at 75 or younger; 19 take children under 18; 35 take healthy volunteers.

This study: 40 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Colonic Neoplasms with a site in Portugal, or all of them as a file.
02

Study summary

Colorectal cancer (CRC) is a leading cause of cancer death and its' incidence is rising in most European countries. Colonoscopy has been shown to reduce CRC incidence, however its effectiveness depends on the sensitivity to detect pre-malignant lesions.

Our aim is to evaluate narrow band imaging (NBI) during colonoscopy and serum miRNAs as novel tools for the early detection of colonic sessile serrated lesions (SSL). The investigators will perform a multicenter-randomized-controlled-trial to study the role of NBI in SSL detection.

03

Conditions studied

  • Colon Cancer
  • Colon Sessile Serrated Adenoma/Polyp
04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients scheduled for elective colonoscopies

Exclusion criteria

Exclusion Criteria:

  • known polyposis syndromes
  • primary sclerosing cholangitis
  • inflammatory bowel disease
  • personal colorectal cancer history
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
987 participants (estimated)

Study arms

  • Experimental
    Narrow band imaging withdrawal

    colonoscope withdrawal and mucosal inspection performed under narrow band imaging

    Device: narrow band imaging withdrawal

  • Placebo comparator
    white light withdrawal

    colonoscope withdrawal and mucosal inspection performed under white light imaging

    Device: white light withdrawal

Interventions

  • Devicenarrow band imaging withdrawal

    colonoscope withdrawal and mucosal inspection performed under narrow band imaging

  • Devicewhite light withdrawal

    colonoscope withdrawal and mucosal inspection performed under white light imaging

06

What researchers measure

Primary outcomes

  1. average number of serrated lesions ≥10 mm detected per colonoscopy

    Time frame: immediate

Secondary outcomes

  1. Serrated class lesions detection rate

    number of patients with at least 1 lesion/total number of participants

    Time frame: immediate

  2. Serrated lesions <10 mm detected per colonoscopy

    Time frame: immediate

  3. SSL detection rate

    histologically defined according to the WHO criteria

    Time frame: immediate

  4. Adenoma detection rate

    number of patients with at least 1 adenoma/total number of participants

    Time frame: immediate

  5. Adenomas detected per colonoscopy

    Time frame: immediate

  6. Advanced (malignant) adenocarcinoma detection rate

    Time frame: immediate

  7. Incidence of procedure related adverse events

    Time frame: immediate

07

Study locations

1 of 3 sites recruiting
  • Hospital Beatriz Ângelo
    Loures, Portugal
    Recruiting
  • Centro Hospitalar do Porto
    Porto, Portugal
    Not yet recruiting
  • Instituto Português de Oncologia do Porto
    Porto, Portugal
    Not yet recruiting
08

References and documents

Publications

  • Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, Goldblum JR, Guillem JG, Kahi CJ, Kalady MF, O'Brien MJ, Odze RD, Ogino S, Parry S, Snover DC, Torlakovic EE, Wise PE, Young J, Church J. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012 Sep;107(9):1315-29; quiz 1314, 1330. doi: 10.1038/ajg.2012.161. Epub 2012 Jun 19. PubMed 22710576 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2016, a primary completion of Aug 2019 and a completion of Aug 2019. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2016
First posted
Aug 23, 2016
Start
Nov 2016
Primary completionEst.
Aug 2019
CompletionEst.
Aug 2019
Last update
Sep 26, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02876133
Lead sponsor
Hospital Beatriz Ângelo
Responsible party
Alexandre Ferreira (Gastroenterologist, Hospital Beatriz Ângelo) — Principal investigator
First posted
Aug 23, 2016
Start date
Nov 2016
Primary completion
Aug 2019 (estimated)
Completion
Aug 2019 (estimated)
Last update
Sep 26, 2018

Study contacts

Alexandre O Ferreira, MD
Contact
alex.gastrohep@gmail.com
Alexandre O Ferreira, MD
principal investigator · Hospital Beatriz Ângelo

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion